Physician profile
Peter A Netland
NPI 1700843133
$35,314.62
in general payments reported to CMS, 2019-2025
12 companies · $737 in 2025
The $737 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,959 · 2020: $76.08 · 2021: $30K · 2022: $1,337 · 2023: $772 · 2024: $414 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,923.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $32,969.04 | 2019-2025 | Clearpath, Streamline, Kahook Dual Blade |
| Abbvie INC. | $1,038.27 | 2022-2025 | |
| Allergan, INC. | $382.13 | 2019-2021 | |
| Alcon Vision LLC | $370.46 | 2019-2025 | Clareon, Clareon Panoptix Pro, Unity |
| Bausch & Lomb Americas INC. | $139.64 | 2023 | |
| Novartis Pharmaceuticals Corporation | $104.95 | 2019 | |
| Mallinckrodt Hospital Products INC. | $99.99 | 2023 | Acthar |
| Biotissue Holdings INC. | $89.91 | 2024 | |
| Aerie Pharmaceuticals, INC. | $56.92 | 2019 | |
| Heidelberg Engineering, INC. | $38.03 | 2023 | Spectralis |
| Rayner Intraocular Lenses Limited | $25.28 | 2025 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Netland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.